Atlas Trials

Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

Clinical trial NCT04915287 · UNKNOWN

Trial details

NCT number
NCT04915287
Sponsor
Chinese PLA General Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Thrombocytopenia; DrugsChronic Liver Disease
Start date
2021-06-06
Primary completion
2023-06-30
Enrollment
476

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.